OCT and OCT-A Afer Diabetic Vitrectomy in PDR

Launched by ASSIUT UNIVERSITY · Jul 4, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at changes in the eye, specifically at the macula (the central part of the retina responsible for vision), after a surgery called Pars Plana Vitrectomy (PPV). This surgery is performed on patients with complicated Proliferative Diabetic Retinopathy (PDR), which can cause serious vision problems due to issues like bleeding in the eye or the retina being pulled out of place. The goal is to see if there are any structural or blood vessel changes in the macula after the surgery.

To participate in this trial, candidates must have complicated PDR that includes persistent bleeding or retinal detachment that affects the macula. Unfortunately, people who have cloudy vision due to other eye problems after their surgery won't be able to join. Those who do participate will help researchers understand the effects of this surgery on the macula, which could improve future treatments for PDR. This trial is not yet recruiting participants, and it welcomes individuals of all ages and genders who meet the criteria.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Cases with complicated PDR as persistant vitreous hemorrhage or tractional retinal detachment involving or threatening the macula underwent PPV with or without ILM peeling
• Exclusion Criteria:
• • eyes with media opacity after PPV not allowing imaging of the macula